Stockholders' Equity, Comprehensive Income and Share-Based Compensation (Tables)

3 Months Ended

Jan. 29, 2023

Equity [Abstract]

Schedule of Components of Accumulated Other Comprehensive Loss, After-Tax Basis

Changes in the components of accumulated other comprehensive income (AOCI), net of tax, were as follows:

 

	Unrealized Gain (Loss) on Investments, Net		Unrealized Gain (Loss) on Derivative Instruments Qualifying as Cash Flow Hedges		Defined and Postretirement Benefit Plans		Cumulative Translation Adjustments		Total
	(in millions)
Balance as of October 30, 2022	$	(75)	$	(52)	$	(88)	$	13	$	(202)
Other comprehensive income (loss) before reclassifications	17		(38)		—		—		(21)
Amounts reclassified out of AOCI	6		(18)		—		—		(12)
Other comprehensive income (loss), net of tax	23		(56)		—		—		(33)
Balance as of January 29, 2023	$	(52)	$	(108)	$	(88)	$	13	$	(235)

	Unrealized Gain (Loss) on Investments, Net		Unrealized Gain (Loss) on Derivative Instruments Qualifying as Cash Flow Hedges		Defined and Postretirement Benefit Plans		Cumulative Translation Adjustments		Total
	(in millions)
Balance as of October 31, 2021	$	(1)	$	(103)	$	(169)	$	13	$	(260)
Other comprehensive income (loss) before reclassifications	(12)		4		—		—		(8)
Amounts reclassified out of AOCI	(3)		(7)		—		—		(10)
Other comprehensive income (loss), net of tax	(15)		(3)		—		—		(18)
Balance as of January 30, 2022	$	(16)	$	(106)	$	(169)	$	13	$	(278)

Schedule of Stock Repurchases

The following table summarizes our stock repurchases for the three months ended January 29, 2023 and January 30, 2022:

	Three Months Ended
	January 29, 2023		January 30, 2022
	(in millions, except per share amount)
Shares of common stock repurchased	2		12
Cost of stock repurchased	$	250	$	1,803
Average price paid per share	$	103.37	$	145.85

Schedule of Effect of Share-Based Compensation on The Results of Operations

The effect of share-based compensation on the results of operations was as follows: 

	Three Months Ended
	January 29, 2023		January 30, 2022
	(In millions)
Cost of products sold	$	54	$	42
Research, development and engineering	54		43
Marketing and selling	17		14
General and administrative	23		19
Total share-based compensation	$	148	$	118

Schedule of Restricted Stock Units And Restricted Stock Activity

A summary of the changes in restricted stock units, restricted stock, performance share units and performance units outstanding under our equity compensation plans during the three months ended January 29, 2023 is presented below:

	Shares	Weighted Average Grant Date Fair Value
	(In millions, except per share amounts)
Outstanding as of October 30, 2022	11	$	92.31
Granted	5	$	102.84
Vested	(4)	$	70.61
Canceled	—	$	107.71
Outstanding as of January 29, 2023	12	$	103.81